Comparison of basiliximab vs antithymocyte globulin for induction in pediatric heart transplant recipients: An analysis of the International Society for Heart and Lung Transplantation database.

MLA

Butts, Ryan J., et al. “Comparison of Basiliximab vs Antithymocyte Globulin for Induction in Pediatric Heart Transplant Recipients: An Analysis of the International Society for Heart and Lung Transplantation Database.” Pediatric Transplantation, vol. 22, no. 4, June 2018, p. 1–N.PAG. EBSCOhost, https://doi.org/10.1111/petr.13190.

APA

Butts, R. J., Dipchand, A. I., Sutcliffe, D., Bano, M., Dimas, V., Morrow, R., Das, B., & Kirk, R. (2018). Comparison of basiliximab vs antithymocyte globulin for induction in pediatric heart transplant recipients: An analysis of the International Society for Heart and Lung Transplantation database. Pediatric Transplantation, 22(4), 1–N.PAG. https://doi.org/10.1111/petr.13190

Chicago

Butts, Ryan J., Anne I. Dipchand, David Sutcliffe, Maria Bano, Vivian Dimas, Robert Morrow, Bibhuti Das, and Richard Kirk. 2018. “Comparison of Basiliximab vs Antithymocyte Globulin for Induction in Pediatric Heart Transplant Recipients: An Analysis of the International Society for Heart and Lung Transplantation Database.” Pediatric Transplantation 22 (4): 1–N.PAG. doi:10.1111/petr.13190.